Hydrochloric Acid

Hydrochloric Acid

SCHEMBL3667602

CC1=C(C)C(C)(C)C([Ti])=C1C.Cl

nearest known ligand 0.33

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ABL1ACEACHEACVR1ADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ADRB3AGTR1ALKAVPR1AAVPR2BCHEBCRCA2CACNA1ACACNA1BCACNA1CCACNA1DCACNA1ECACNA1FCACNA1GCACNA1HCACNA1ICACNA1SCACNA2D1CACNA2D2CACNA2D3CACNA2D4CACNB1CACNB2CACNB3CACNB4CACNG1CACNG2CACNG3CACNG4CACNG5CACNG6CACNG7CACNG8CALCRLCASRCCR5CDK4CDK6CFBCHRM1CHRM2CHRM3CHRM4CHRM5CHRNA1CHRNA3CHRNA7CHRNB1CHRNB4CHRNDCHRNECHRNGCOXFA4COXFA4L2CRBNCSF1RCUL4ACYP19A1DDB1DPP4DRD1DRD2DRD3DRD4EDNRAEGFREML4ERBB2ERBB4ESR1ESR2FGFR1FGFR3FLT1FLT3FLT4GAAGABRA1GABRA2GABRA3GABRA4GABRA5GABRA6GABRB1GABRB2GABRB3GABRDGABREGABRG1GABRG2GABRG3GABRPGABRQGHSRGLAGNRHRGPD2GRIN1GRIN2AGRIN2BGRIN2CGRIN2DGRIN3AGRIN3BGSTP1HCN4HCRTR1HCRTR2HDAC1HDAC10HDAC11HDAC2HDAC3HDAC4HDAC5HDAC6HDAC7HDAC8HDAC9HRH1HRH2HRH3HSD11B1HSP90AA1HSP90AB1HTR1AHTR1BHTR1DHTR1EHTR1FHTR2AHTR2BHTR2CHTR3AHTR3BHTR3CHTR3DHTR3EHTR4HTR5AHTR6HTR7IMPDH1IMPDH2ITGA2BITGB3ITKJAK1JAK2KCNA1KCNA10KCNA2KCNA3KCNA4KCNA5KCNA6KCNA7KCNB1KCNB2KCNC1KCNC2KCNC3KCNC4KCND1KCND2KCND3KCNF1KCNG1KCNG2KCNG3KCNG4KCNH1KCNH2KCNH3KCNH4KCNH5KCNH6KCNH7KCNH8KCNJ2KCNJ3KCNJ5KCNK3KCNK9KCNQ1KCNQ2KCNQ3KCNQ4KCNQ5KCNS1KCNS2KCNS3KCNV1KCNV2KDRKITKLKB1LCKMMAOAMAOBMAPK14METMMP1MMP13MMP7MMP8MT-ND1MT-ND2MT-ND3MT-ND4MT-ND4LMT-ND5MT-ND6NDUFA1NDUFA10NDUFA11NDUFA12NDUFA13NDUFA2NDUFA3NDUFA5NDUFA6NDUFA7NDUFA8NDUFA9NDUFAB1NDUFAF1NDUFAF2NDUFAF3NDUFAF4NDUFB1NDUFB10NDUFB11NDUFB2NDUFB3NDUFB4NDUFB5NDUFB6NDUFB7NDUFB8NDUFB9NDUFC1NDUFC2NDUFS1NDUFS2NDUFS3NDUFS4NDUFS5NDUFS6NDUFS7NDUFS8NDUFV1NDUFV2NDUFV3NR3C1NS5ANTRK1NTRK2NTRK3ODC1OPRD1OPRK1OPRM1P2RY12PAHPARP1PDE3APDE3BPDE4APDE4BPDE4CPDE4DPDE5APDE7APDE7BPDE8APDE8BPDGFRAPDGFRBPIK3CAPIK3CDPNPPOLA1POLA2POLD1POLD2POLD3POLD4POLEPOLE2POLE3PPARGPRIM1PRIM2PRKCAPRKCBPRKCDPRKCEPRKCGPRKCHPRKCIPRKCQPRKCZPRKD1PRKD3PTGS1PTGS2RBX1RENRETROCK1ROCK2RPE65RRM1RRM2RRM2BS1PR1S1PR2S1PR3S1PR4S1PR5SCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASCNN1ASCNN1BSCNN1GSIGMAR1SLC18A2SLC6A1SLC6A2SLC6A3SLC6A4SLC9A3SRCTACR1TOP1TOP2ATOP2BTTRTYMPdacAdacBdacCembAfolAftsIgyrAgyrBmrcAmrcBmrdAparCparEpolrplArplBrplCrplDrplErplFrplIrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmE2rpmFrpmGrpmG1rpmG2rpmG3rpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO

The experimentally established mechanism targets of Hydrochloric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
CTSD P07339 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL812503 1.00 CTSD (0.33) CTSD
Hydrochloric Acid SCHEMBL138585 1.00 CTSD (0.33) CTSD
Ethane SCHEMBL9190139 0.97 CTSD (0.32) CTSD
Methane SCHEMBL9190165 0.97 CTSD (0.32) CTSD
SCHEMBL140407 0.97 CTSD (0.35) CTSD
Methyl Alcohol SCHEMBL9190282 0.95 CTSD (0.31) CTSD
Bromide SCHEMBL27948710 0.94 CTSD (0.33) CTSD
Fluoride SCHEMBL27933141 0.94 CTSD (0.33) CTSD
Iodide SCHEMBL27933185 0.94 CTSD (0.33) CTSD
Bromide SCHEMBL1539651 0.94 CTSD (0.33) CTSD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 19 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2344552-B1 METHOD FOR PREPARING ELASTOMERIC COPOLYMERS OF ETHYLENE AND ALPHA-OLEFINS SABIC SK NEXLENE COMPANY PTE LTD (SG) 2018-08-01 EP disclosed
EP-2324067-B1 ETHYLENE COPOLYMER AND A METHOD OF PREPARING THE SAME SABIC SK NEXLENE COMPANY PTE LTD (SG) 2018-04-25 EP disclosed
EP-2225251-B1 TRANSITION METAL COMPLEXES, CATALYSTS COMPOSITION CONTAINING THE SAME, AND PROCESS FOR PREPARING ETHYLENE HOMOPOLYMERS OR COPOLYMERS OF ETHYLENE AND ALPHA-OLEFINS USING THE SAME SABIC SK NEXLENE COMPANY PTE LTD (SG) 2015-12-23 EP disclosed
EP-2010576-B1 BIS-ARYLARYLOXY CATALYTIC SYSTEM FOR PRODUCING ETHYLENE HOMOPOLYMERS OR ETHYLENE COPOLYMERS WITH ALPHA-OLEFINS SK INNOVATION CO LTD (KR) 2013-07-24 EP disclosed
EP-2077270-B1 Transition metal complexes, and catalysts compositions for preparing ethylene homopolymers or copolymers SK INNOVATION CO LTD (KR) 2013-03-20 EP disclosed
US-8344081-B2 Transition metal complexes, catalysts composition containing the same, and process for preparing ethylene homopolymers or copolymers of ethylene and alpha-olefins using the same SK INNOVATION CO., LTD. (KR) 2013-01-01 US disclosed
CN-102083871-A Process for the preparation of elastomeric copolymers of ethylene and alpha-olefins SK ENERGY CO LTD 2011-06-01 CN disclosed
CN-101910187-A Transition metal complex, catalyst composition containing the same, and method for preparing ethylene homopolymer or copolymer of ethylene and alpha-olefin using the complex and the composition SK ENERGY CO LTD 2010-12-08 CN disclosed
US-7847039-B2 transition metal catalyst having a cyclopentadiene derivative and an aryl oxide ligand with a heteroaryl derivative at the ortho-position as polymerization catalysts for high molecular weight ethylene homo- or copolymers; e.g. (dichloro)(pentamethylcyclopentadienyl)(2-thiophen-2'-yl)phenoxy)titanium(IV) SK ENERGY CO., LTD. (KR) 2010-12-07 US disclosed
US-20100298512-A1 TRANSITION METAL COMPLEXES, CATALYSTS COMPOSITION CONTAINING THE SAME, AND PROCESS FOR PREPARING ETHYLENE HOMOPOLYMERS OR COPOLYMERS OF ETHYLENE AND ALPHA-OLEFINS USING THE SAME SK ENERGY CO., LTD. (KR) 2010-11-25 US disclosed
EP-2225251-A1 TRANSITION METAL COMPLEXES, CATALYSTS COMPOSITION CONTAINING THE SAME, AND PROCESS FOR PREPARING ETHYLENE HOMOPOLYMERS OR COPOLYMERS OF ETHYLENE AND ALPHA-OLEFINS USING THE SAME SK Energy Co., Ltd. (KR) 2010-09-08 EP disclosed
CN-101796085-A Ethylene copolymers having multimodal molecular weight distribution and process for their preparation SK ENERGY CO LTD 2010-08-04 CN disclosed
US-20100120981-A1 ETHYLENE COPOLYMER AND A METHOD OF PREPARING THE SAME SABIC SK NEXLENE COMPANY PTE. LTD. (SG) 2010-05-13 US disclosed
US-20100113720-A1 METHOD FOR PREPARING ELASTOMERIC COPOLYMERS OF ETHYLENE AND ALPHA-OLEFINS SABIC SK NEXLENE COMPANY PTE. LTD. (SG) 2010-05-06 US disclosed
US-20090176948-A1 Transition metal complexes, and catalysts compositions for preparing ethylene homopolymers or copolymers SABIC SK NEXLENE COMPANY PTE. LTD. (SG) 2009-07-09 US disclosed
WO-2009084805-A1 TRANSITION METAL COMPLEXES, CATALYSTS COMPOSITION CONTAINING THE SAME, AND PROCESS FOR PREPARING ETHYLENE HOMOPOLYMERS OR COPOLYMERS OF ETHYLENE AND ALPHA-OLEFINS USING THE SAME SK ENERGY CO., LTD. (KR) 2009-07-09 WO disclosed
EP-2077270-A1 Transition metal complexes, and catalysts compositions for preparing ethylene homopolymers or copolymers SK Energy Co., Ltd. (KR) 2009-07-08 EP disclosed
CN-1278265-A Process for preparing fulvene metal complexes BAYER AG (DE) 2000-12-27 CN disclosed
US-5430001-A Process for producing a styrene polymer and a catalyst for use therein IDEMITSU KOSAN CO., LTD. (JP) 1995-07-04 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090176948-A1 Transition metal complexes, and catalysts compositions for preparing ethylene homopolymers or copolymers ETV6, OXER1, AP1M1 CTSD 2472/4885
US-20100298512-A1 TRANSITION METAL COMPLEXES, CATALYSTS COMPOSITION CONTAINING THE SAME, AND PROCESS FOR PREPARING ETHYLENE HOMOPOLYMERS OR COPOLYMERS OF ETHYLENE AND ALPHA-OLEFINS USING THE SAME MCM4, ESR1, SEM1 CTSD 2906/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.